title: Delayed onset perforating folliculitis associated with sorafenib.
authors.affiliation: Department of Dermatology, Hospital Álvarez-Buylla, Mieres, Spain.
authors.forename: Ana
authors.initials: A
authors.lastname: Batalla
authors.forename: Lucía
authors.initials: L
authors.lastname: Menéndez
authors.forename: Pilar
authors.initials: P
authors.lastname: Blay
authors.forename: José Ramón
authors.initials: JR
authors.lastname: Curto
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005499:Folliculitis / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000009:adverse effects*; D000077157:Sorafenib; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib